First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

521 Reviews

Credit Rating - LENA NANOCEUTICS LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: LENA NANOCEUTICS LIMITED, INSTITUTE OF PHARMACEUTICAL INNO, RICHMOND ROAD, BRADFORD, WEST YORKSHIRE, BD7 1DP. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 28 February 2019. The company was incorporated on 6 April 2006.

The accounts next due date is 30 November 2020. There are no mortgages.

The above was based on public record information as at 16 April 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 05773005
Date Incorporated: 6 April 2006
Date Latest Accounts: 28 February 2019
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: L&P 159 LIMITED
Registered Number: 05773005
Annual Return: 6 April 2016
Registered Office: INSTITUTE OF PHARMACEUTICAL INNO, RICHMOND ROAD, BRADFORD, WEST YORKSHIRE, BD7 1DP
SIC Code and Operations: 72190
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

LENA NANOCEUTICS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 26 April 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
12164977 LENA NUNKOO LTD Active - Proposal to Strike off
09266736 LENA OLUND LIMITED Active
10108719 LENA ONLINE LIMITED Dissolved
11936102 LENA ORBELL LTD Active - Proposal to Strike off
15457482 LENA OT LIMITED Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd